Technology news and Jobs 
Science FDA announces first-time list of "potential" problem drugs
Science FDA announces first-time list of "potential" problem drugs | FDA announces first-time list of "potential" problem drugs |
|
| by William Atkins | |
| Monday, 08 September 2008 | |
|
Page 2 of 2 The list of drug products, with its active ingredient (trade name) or product class, along with their potential signs of serious risk is shown below: Featured Whitepaper
5 Best Practices for Smartphone Support
Science Discussionso pediatric overdose due to labeling/packaging confusion • Desflurane (Suprane), an anesthetic o cardiac arrest • Duloxetine (Cymbalta), for depression and other conditions o Urinary retention • Etravirine (Intelence), an HIV medication, bleeding into joints o Hemarthrosis • Fluorouracil Cream (Carac) and Ketoconazole Cream (Kuric), creams for skin conditions and fungal infections o Adverse events due to name confusion • Heparin, a blood-thinner, serious allergic reactions o Anaphylactic-type reactions • Icodextrin (Extraneal), used in kidney dialysis, low blood sugars o Hypoglycemia • Insulin U-500 (Humulin R), insulin for diabetes o Dosing confusion • Ivermectin (Stromectol) and Warfarin, an anti-parasite drug and a blood thinner o Drug interaction • Lapatinib (Tykerb), for advanced breast cancer, liver damage o Hepatotoxicity • Lenalidomide (Revlimid), for multiple myeloma, severe skin blistering and bleeding o Stevens Johnson Syndrome • Natalizumab (Tysabri), for multiple sclerosis o Skin melanomas. • Nitroglycerin (Nitrostat), for angina, o Overdose due to labeling confusion • Octreotide Acetate Depot (Sandostatin LAR), for abnormal bone growth, bowel obstruction o Ileus • Oxycodone Hydrochloride Controlled-Release (Oxycontin), a pain killer o Drug misuse, abuse and overdose • Perflutren Lipid Microsphere (Definity), used in cardiac imaging o Cardiopulmonary reactions • Phenytoin Injection (Dilantin), for epileptic seizures, serious skin reaction o Purple Glove Syndrome • Quetiapine (Seroquel), for bipolar disorder o Overdose due to sample pack labeling confusion • Telbivudine (Tyzeka), for chronic hepatitis B, nerve damage o Peripheral Neuropathy • Tumor Necrosis Factor (TNF) Blockers, for juvenile arthritis o Cancers in children and young adults The list also appears on the FDA website “Potential Signals of Serious Risks/New Safety Information Identified by the Adverse Event Reporting System (AERS) January - March 2008.” |
Tags
| < Next story in category | Previous story in the category > |
|---|
